Scholars@Duke
David Blaine Ridley

David Blaine Ridley

Professor of the Practice of Business Administration
Fuqua School of Business
david.ridley@duke.edu
Duke Box 90120, 100 Fuqua Drive, Durham, NC 27708-0120
100 Fuqua Drive, Durham, NC 27708-0120

In the News

Published February 6, 2023
Needed: A Kickstart to Innovation in Slowing the Spread of Malaria
Published June 10, 2021
Launch Prices for New Drugs Have Doubled Since 2005
Published June 18, 2018
Federal Review Protocol Suggested by Duke Faculty Approves Drug for Neglected Tropical Disease
Published January 26, 2018
The economist behind the ‘priority review voucher,’ which advances treatments for neglected diseases.
Published December 14, 2017
When the U.S. Spends More on Fighting a Disease, the Rest of the World Spends Less
Published August 9, 2017
Fuqua Insights: A Proposal to Generate Insecticides that Could Save Millions of Lives
Published June 27, 2016
Low prices for vaccines can come at a great cost
Published May 5, 2016
Fuqua Research Urges Caution in Expansion of Drug Development Incentive Program
Published March 28, 2016
Infectious Disease Symposium Convenes at Duke April 1
Published February 8, 2016
Fuqua Professor David Ridley Explores Tensions in the Vaccine Market
Published September 3, 2015
Fuqua Research on Why Timing Is Important in Launching New Pharmaceuticals
Published August 20, 2015
Price rises for ticket to a quicker drug review by FDA
Published August 20, 2015
How Duke Fuqua profs connect to a $350M pharma transaction
Published March 6, 2015
DIW Office Connects Duke Experts to Washington
Published October 28, 2014
David Ridley: The little-known federal program that could speed up an Ebola cure
Published October 13, 2014
Editorial: Containing Ebola will require powerful new weapons
Published October 8, 2014
David Ridley: Give drug companies more incentive to fight Ebola
Published October 8, 2014
Give Drug Companies More Incentive to Fight Ebola